title: Updates in the management of high-grade glioma.
abstract: The management of high-grade glioma (HGG) has evolved significantly over the last decade. Patients are managed in a multidisciplinary team setting in order to ensure their care is guided by the most current evidenced based treatments. The outcome in patients with HGG, while still poor, has improved in terms of both survival and quality of life during illness. This review discusses a number of developments seen in the management of HGG over the last 5 years.
authors.affiliation: The National Hospital for Neurology and Neurosurgery, Queen Square, Mailbox 99, London, WC1N 3BG, UK, davidbradley@physicians.ie.
authors.forename: David
authors.initials: D
authors.lastname: Bradley
authors.forename: Jeremy
authors.initials: J
authors.lastname: Rees
mesh_terms: D001932:Brain Neoplasms / Q000473:pathology / Q000523:psychology / Q000628:therapy*; D059248:Chemoradiotherapy; D059186:Chemoradiotherapy, Adjuvant; D019468:Disease Management; D005909:Glioblastoma / Q000473:pathology / Q000628:therapy; D005910:Glioma / Q000473:pathology / Q000523:psychology / Q000628:therapy*; D006801:Humans; D011788:Quality of Life; D016019:Survival Analysis; D016896:Treatment Outcome